R. MATTHEW KANE - President and CEO, Director at PRECISION BIOSCIENCES INC

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
DTIL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by R. MATTHEW KANE since 10 Jan 2025

Holdings reported by R. MATTHEW KANE for PRECISION BIOSCIENCES INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,013,597 $745,031 $0.3700 13 May 2021 Direct
Common Stock 10,841 $4,011 $0.3700 13 May 2021 By Spouse
Restricted Stock Units 763 $282 $0.3700 07 Jun 2021 By Spouse Common Stock
Employee Stock Option (Right to Buy) 1,312 07 Jun 2021 By Spouse Common Stock
Employee Stock Option (Right to Buy) 0 13 May 2021 Direct Common Stock

Transactions reported by R. MATTHEW KANE for PRECISION BIOSCIENCES INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.